Fidelity Investments’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.4M | Buy |
5,293,369
+98,075
| +2% | +$934K | ﹤0.01% | 1392 |
|
|
2025
Q1 | $54.3M | Sell |
5,195,294
-2,801,637
| -35% | -$29.3M | ﹤0.01% | 1325 |
|
|
2024
Q4 | $188M | Sell |
7,996,931
-1,029,766
| -11% | -$24.3M | 0.01% | 851 |
|
|
2024
Q3 | $324M | Buy |
9,026,697
+3,707,734
| +70% | +$133M | 0.02% | 638 |
|
|
2024
Q2 | $188M | Buy |
5,318,963
+2,100,570
| +65% | +$74.1M | 0.01% | 805 |
|
|
2024
Q1 | $91.4M | Buy |
3,218,393
+1,935,581
| +151% | +$55M | 0.01% | 1095 |
|
|
2023
Q4 | $17.1M | Buy |
1,282,812
+436,452
| +52% | +$5.8M | ﹤0.01% | 1680 |
|
|
2023
Q3 | $7.58M | Sell |
846,360
-52,932
| -6% | -$474K | ﹤0.01% | 1919 |
|
|
2023
Q2 | $10.1M | Buy |
899,292
+490,236
| +120% | +$5.52M | ﹤0.01% | 1858 |
|
|
2023
Q1 | $4.71M | Sell |
409,056
-165,064
| -29% | -$1.9M | ﹤0.01% | 2117 |
|
|
2022
Q4 | $6.65M | Buy |
574,120
+500,878
| +684% | +$5.81M | ﹤0.01% | 2034 |
|
|
2022
Q3 | $930K | Buy |
73,242
+409
| +0.6% | +$5.19K | ﹤0.01% | 2623 |
|
|
2022
Q2 | $500K | Buy |
72,833
+66
| +0.1% | +$453 | ﹤0.01% | 2846 |
|
|
2022
Q1 | $701K | Buy |
72,767
+55,567
| +323% | +$535K | ﹤0.01% | 2878 |
|
|
2021
Q4 | $205K | Buy |
+17,200
| New | +$205K | ﹤0.01% | 2953 |
|
|
2021
Q2 | – | Sell |
-211,483
| Closed | -$3.28M | – | 4388 |
|
|
2021
Q1 | $3.28M | Buy |
211,483
+93,883
| +80% | +$1.46M | ﹤0.01% | 2360 |
|
|
2020
Q4 | $2.47M | Hold |
117,600
| – | – | ﹤0.01% | 2361 |
|
|
2020
Q3 | $2.37M | Buy |
+117,600
| New | +$2.37M | ﹤0.01% | 2267 |
|